These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 17436432)

  • 1. Five-gene signature in non-small-cell lung cancer.
    Raz DJ; Jablons DM
    N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436432
    [No Abstract]   [Full Text] [Related]  

  • 2. Validation of a reverse transcription-polymerase chain reaction-based five-gene signature in non-small cell lung cancer.
    Ruco L; Scarpino S; Natoli G
    J Thorac Oncol; 2009 May; 4(5):670. PubMed ID: 19395916
    [No Abstract]   [Full Text] [Related]  

  • 3. Five-gene signature in non-small-cell lung cancer.
    Gounaris I
    N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436431
    [No Abstract]   [Full Text] [Related]  

  • 4. A five-gene signature and clinical outcome in non-small-cell lung cancer.
    Chen HY; Yu SL; Chen CH; Chang GC; Chen CY; Yuan A; Cheng CL; Wang CH; Terng HJ; Kao SF; Chan WK; Li HN; Liu CC; Singh S; Chen WJ; Chen JJ; Yang PC
    N Engl J Med; 2007 Jan; 356(1):11-20. PubMed ID: 17202451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miRNA signatures: promising prognostic tools for cancer.
    Heneghan HM; Miller N; Kerin MJ
    J Clin Oncol; 2010 Oct; 28(29):e573-4; author reply e575-6. PubMed ID: 20697097
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene signature for predicting NSCLC outcome.
    Sharma SP
    Lancet Oncol; 2007 Feb; 8(2):105. PubMed ID: 17288046
    [No Abstract]   [Full Text] [Related]  

  • 7. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.
    Lu Y; Lemon W; Liu PY; Yi Y; Morrison C; Yang P; Sun Z; Szoke J; Gerald WL; Watson M; Govindan R; You M
    PLoS Med; 2006 Dec; 3(12):e467. PubMed ID: 17194181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refining prognosis in non-small-cell lung cancer.
    Sun Z; Yang P
    N Engl J Med; 2007 Jan; 356(2):189-90; author reply 190-1. PubMed ID: 17215540
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular signatures of lung cancer--toward personalized therapy.
    Herbst RS; Lippman SM
    N Engl J Med; 2007 Jan; 356(1):76-8. PubMed ID: 17202459
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
    Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
    Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene profiling of clinical routine biopsies and prediction of survival in non-small cell lung cancer.
    Baty F; Facompré M; Kaiser S; Schumacher M; Pless M; Bubendorf L; Savic S; Marrer E; Budach W; Buess M; Kehren J; Tamm M; Brutsche MH
    Am J Respir Crit Care Med; 2010 Jan; 181(2):181-8. PubMed ID: 19833826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-gene signature in non-small-cell lung cancer.
    Quintás-Cardama A; Gibbons DL
    N Engl J Med; 2007 Apr; 356(15):1582-3; author reply 1583. PubMed ID: 17436429
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene expression profiles of non-small cell lung cancer: survival prediction and new biomarkers.
    Välk K; Vooder T; Kolde R; Reintam MA; Petzold C; Vilo J; Metspalu A
    Oncology; 2010; 79(3-4):283-92. PubMed ID: 21412013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.
    Hu Z; Chen X; Zhao Y; Tian T; Jin G; Shu Y; Chen Y; Xu L; Zen K; Zhang C; Shen H
    J Clin Oncol; 2010 Apr; 28(10):1721-6. PubMed ID: 20194856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular prognostication of non-small cell lung cancer.
    Tsao MS; Jablons DM
    Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
    [No Abstract]   [Full Text] [Related]  

  • 16. Five-gene signature in non-small-cell lung cancer.
    Michiels S; Hill C
    N Engl J Med; 2007 Apr; 356(15):1581-2; author reply 1583. PubMed ID: 17429092
    [No Abstract]   [Full Text] [Related]  

  • 17. A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors.
    Kratz JR; Van den Eeden SK; He J; Jablons DM; Mann MJ
    JAMA; 2012 Oct; 308(16):1629-31. PubMed ID: 23093159
    [No Abstract]   [Full Text] [Related]  

  • 18. Five-gene signature in non-small-cell lung cancer.
    Dobbin KK
    N Engl J Med; 2007 Apr; 356(15):1582; author reply 1583. PubMed ID: 17436430
    [No Abstract]   [Full Text] [Related]  

  • 19. Survivin and Smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery.
    Dai CH; Li J; Shi SB; Yu LC; Ge LP; Chen P
    Jpn J Clin Oncol; 2010 Apr; 40(4):327-35. PubMed ID: 20056675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis.
    Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y
    Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.